期刊文献+

西格列汀联合甘精胰岛素治疗糖尿病的应用体会 被引量:4

Application experience on Sitagliptin combined with Insulin Glargine in the treatment of diabetes mellitus
暂未订购
导出
摘要 目的探讨西格列汀联合甘精胰岛素治疗糖尿病的效果。方法选取2011年11月~2012年4月于本院进行治疗的46例初发的糖尿病患者为研究对象,将其随机分为观察组(西格列汀联合甘精胰岛素组)和对照组(阿卡波糖联合甘精胰岛素组),每组各23例,将两组的疗效进行比较。结果观察组的血糖控制达标时间较对照组缩短,而甘精胰岛素的最终剂量较对照组减少,均P<0.05,差异均有统计学意义。结论西格列汀联合甘精胰岛素治疗初发的糖尿病的效果值得肯定。 Objective To study the effect of Sitagliptin combined with Insulin Glargine in the treatment of diabetes mellitus.Methods Forty-six patients with incipient diabetes were selected as research object in our hospital from November 2011 to April 2012,and they were randomly divided into observation group (Sitagliptin combined with Insulin Glargine group) and control group (Acarbose combined with Insulin Glargine group),with 23 cases in each group,then the curative effect of two groups were compared.Results The time of observation group's blood glucose achieving goal was shorter than that of control group,the final dose of Insulin Glargine was smaller than that of control group,all P 0.05,there were all significant differences.Conclusion The Sitagliptin combined with Insulin Glargine in the treatment of diabetes mellitus is confirmed.
出处 《中国当代医药》 2012年第33期52-53,共2页 China Modern Medicine
关键词 西格列汀 糖尿病 甘精胰岛素 应用体会 Sitagliptin Diabetes mellitus Insulin glargine Application experience
  • 相关文献

参考文献8

二级参考文献74

  • 1陈超,莫尉林,邢学农,李素梅,叶山东,任安.甘精胰岛素、NPH胰岛素联合口服降糖药在2型糖尿病患者中的应用[J].安徽医学,2006,27(4):262-264. 被引量:4
  • 2刘新艮.实用内分泌学[M].第3版.北京:人民军医出版社,2004.1182.
  • 3Buse JB,Polonsky KS,Burant CF.Type 2 diabetes mellitus.In:Kronenberg HM,Melreed S,Polonsky KS,et al.Williams Textbook of Endo crinology[M].11th ed.Philadelphia,PA:Saunders,2008:1329-1389.
  • 4Powers AC.Diabetes mellitus.In:Fauci AS,Braunwald E,Kasper DL,et al,eds.Harrison's Principles Of Internal Medicine[OL].17th ed.New York,NY:McGraw-Hill,OO8.http://www.accessmedicine.com/content.aspx?Aid=2891108.
  • 5Del Prato S,Marchetti P.Beta-and alpha-cell dysfunction in type 2 diabetes[J].Horm Metab Res,2004,36:775-781.
  • 6Muller WA,Faloona GR,Aguilar-Parada E,et al.Abnormal alpha-cell function in diabetes:response to carbohydrate and protein ingestion[J].N Engl J Med,1970,283:109-115.
  • 7Aschner P,Kipnes MS,Lunceford JK,et al.Effect of the dipeptidyl peptidase-f inhibitor sitagliptin as monotherapy on glycemic control in patients woth type 2 diabetes[J].Diabetes Care,2006,29(12):2632-2637.
  • 8Oneline apendex[OL].heep://care.diabetesjournals.org/content/29/12/2632/suppi/DC1.
  • 9Mohan V,Yang W,Son HY,et al.Efficacy and safety of sitagliptin in the treatment of patients with type 2 diabetes in China,Jndia,and korea[J].Diabetes Res Olin Pract,2009,83(1):106-116.
  • 10Mohan V, Yang Wenying, Son HY, et al. Efficacy and safety of sitagliptin in the treatment of patients with type 2 diabetes in China, India, and Korea [ J ]. Diabetes Res Clin Pract ,2009,83 ( 1 ) : 106 - 116.

共引文献77

同被引文献29

引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部